Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Trevena Inc. (TRVN)

0.7517   -0.018 (-2.36%) 02-21 16:00
Open: 0.7644 Pre. Close: 0.7699
High: 0.7699 Low: 0.74
Volume: 461,970 Market Cap: 70M
Trevena Inc is a clinical stage biopharmaceutical company. It discovers, develops and commercialize therapeutics that use a novel approach to target G protein coupled receptors.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.771 - 0.775 0.775 - 0.778
Low: 0.731 - 0.735 0.735 - 0.739
Close: 0.743 - 0.75 0.75 - 0.757

Technical analysis

as of: 2020-02-21 4:34:32 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.04     One year: 1.16
Support: Support1: 0.73    Support2: 0.61
Resistance: Resistance1: 0.89    Resistance2: 0.99
Pivot: 0.81
Moving Average: MA(5): 0.76     MA(20): 0.84
MA(100): 0.83     MA(250): 1.05
MACD: MACD(12,26): -0.03     Signal(9): -0.01
Stochastic oscillator: %K(14,3): 15.29     %D(3): 12.57
RSI: RSI(14): 37.77
52-week: High: 2.00  Low: 0.60  Change(%): -47.4
Average Vol(K): 3-Month: 58097  10-Days: 64352

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
TRVN has closed above bottom band by 20.4%. Bollinger Bands are 8.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 11 Jan 2018 08:18:28 +0000
7 High-Risk, High-Reward Stocks to Buy Now

Tue, 01 Sep 2015 05:12:56 +0000
Mid-Day Market Update: Crude Oil Dips Over 6%; Matrix Service Shares Rise On Earnings Beat

Tue, 01 Sep 2015 14:31:38 +0000
Mid-Morning Market Update: Markets Open Lower; Dollar Tree Posts Q2 Loss

Tue, 19 Mar 2019 09:53:00 +0000
Puma Biotech's (PBYI) Nerlynx Gets Approval in Australia

Fri, 15 Mar 2019 15:25:00 +0000
PDL BioPharma (PDLI) Q4 Earnings Top Mark, Revenues Fall Y/Y

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 92.59
Shares Float (M) 91.71
% Held by Insiders 2.97
% Held by Institutions 21.61
Shares Short (K) 4320
Shares Short P. Month (K)

Stock Financials

EPS -0.296
Book Value (p.s.) 0.370
PEG Ratio
Profit Margin
Operating Margin -10922.41
Return on Assets (ttm) -23.8
Return on Equity (ttm) -63.5
Qtrly Rev. Growth
Gross Profit (p.s.) 0.062
Sales Per Share
EBITDA (p.s.) -0.267
Qtrly Earnings Growth
Operating Cash Flow (M) -22.56
Levered Free Cash Flow (M) -12.40

Stock Valuations

P/E -2.54
P/E Growth Ratio -0.02
P/BV 2.03
P/S
P/CF -3.09

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.